CN103191280A - Tradtional Chinese medicine for treating angiitis - Google Patents

Tradtional Chinese medicine for treating angiitis Download PDF

Info

Publication number
CN103191280A
CN103191280A CN2013101132836A CN201310113283A CN103191280A CN 103191280 A CN103191280 A CN 103191280A CN 2013101132836 A CN2013101132836 A CN 2013101132836A CN 201310113283 A CN201310113283 A CN 201310113283A CN 103191280 A CN103191280 A CN 103191280A
Authority
CN
China
Prior art keywords
radix
chinese medicine
root
fructus
rhizoma atractylodis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013101132836A
Other languages
Chinese (zh)
Inventor
张希富
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013101132836A priority Critical patent/CN103191280A/en
Publication of CN103191280A publication Critical patent/CN103191280A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a tradtional Chinese medicine for treating angiitis, namely No.1 Kangyupai angiitis. The tradional Chinese medicine is prepared from the following Chinese medicinal materials: pilose asiabell root, white atractylodes rhizome, astragalus root, scorpion, centipede, figwort, costus root, yam, divaricate saposhnikovia root, achyranthes root, turtle shell, pangolin scales, red peony root, root-bark of tree peony, peach seeds, skullcap, loofah sponge, atractylodes, kudzuvine root, phellodendron, felwort, fructus evodiae and gardenia. The tradtional Chinese medicine is prepared from 23 gouts of medicinal materials by adopting the measures of decoction, concentration, high-temperature sterilization, rot proofing and the like; the tradtional Chinese medicine has the effects of promoting blood circulation to remove blood stasis and dredging channels; through more than 40 years of clinical verification, the treatment effect of the Chinese medicament is superior to that of current commercial products for treating the angiitis; and the Chinese medicament has the advantages of simplicity, convenience, low cost, strong treatment effect and the like, and eliminates much inconvenience of the conventional similar products.

Description

A kind ofly treat vasculitic Chinese medicine
Technical field
The invention discloses a kind of vasculitic medicine for the treatment of, is the Chinese medicine preparation of feedstock production with Chinese medicine specifically, belongs to the field of Chinese medicines.
Background technology
Vasculitis full name " thromboangiitis obliterans ", it is the allergic inflammation that betides blood vessel, small artery segmental stricture, obturation in causing, acra loses nutrition, ulcer occurs, necrosis, it is a kind of obstinate angiopathy, be not a kind of inflammation performance of blood vessel wall itself, it doesn't matter with bacterial infection.Chinese medicine is attributed to thromboangiitis obliterans " necrosis " category.The cause of disease, symptom prognosis and treatment to necrosis are all on the books, except Chinese medicine for oral administration, also have treatments such as acupuncture, fumigation and wash method and external-applied medicinal powder.Although the modern medicine science is very flourishing, also can only expectant treatment, or operation amputation treatment, bring life, work, the many-sided influence of economic dispatch to the patient.
Summary of the invention
The purpose of this invention is to provide and a kind ofly can treat vasculitic Chinese medicine, treating both the principal and secondary aspects of a disease, have no side effect, curative effect weak point, instant effect, can cure, no Drug resistance.
The present invention is that raw material is processed into Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, the Radix Astragali, Scorpio, Scolopendra, Radix Scrophulariae, the Radix Aucklandiae, Rhizoma Dioscoreae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, Carapax Trionycis, Squama Manis, Radix Paeoniae Rubra, Cortex Moutan, Semen Persicae, Radix Scutellariae, Retinervus Luffae Fructus, Rhizoma Atractylodis, Radix Puerariae, Cortex Phellodendri, Radix Gentianae, Fructus Evodiae, Fructus Gardeniae.
The present invention is a kind of to treat vasculitic Chinese medicine, is to be made by following traditional Chinese medicines weight proportion raw material:
Radix Codonopsis 50-80g, Rhizoma Atractylodis Macrocephalae 50-80g, Radix Astragali 20-30g, Scorpio 20-30g, Scolopendra 20-30g, Radix Scrophulariae 50-80g, Radix Aucklandiae 50-120g, Rhizoma Dioscoreae 50-130g, Radix Saposhnikoviae 50-70g, Radix Achyranthis Bidentatae 20-30g, Carapax Trionycis 20-30g, Squama Manis 20-30g, Radix Paeoniae Rubra 20-30g, Cortex Moutan 20-30g, Semen Persicae 30-40g, Radix Scutellariae 30-50g, Retinervus Luffae Fructus 40-50g, Rhizoma Atractylodis 30-50g, Radix Puerariae 40-50g, Cortex Phellodendri 20-30g, Radix Gentianae 20-30g, Fructus Evodiae 20-30g, Fructus Gardeniae 20-30g.
Each raw material preferred weight proportioning of the present invention: Radix Codonopsis 60g, Rhizoma Atractylodis Macrocephalae 60g, Radix Astragali 25g, Scorpio 25g, Scolopendra 20g, Radix Scrophulariae 55g, Radix Aucklandiae 60g, Rhizoma Dioscoreae 80g, Radix Saposhnikoviae 60g, Radix Achyranthis Bidentatae 25g, Carapax Trionycis 25g, Squama Manis 25g, Radix Paeoniae Rubra 25g, Cortex Moutan 25g, Semen Persicae 35g, Radix Scutellariae 35g, Retinervus Luffae Fructus 45g, Rhizoma Atractylodis 30g, Radix Puerariae 45g, Cortex Phellodendri 25g, Radix Gentianae 25g, Fructus Evodiae 25g, Fructus Gardeniae 25g.
The specific embodiment
Choose high-quality following traditional Chinese medicines material: Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, the Radix Astragali, Scorpio, Scolopendra, Radix Scrophulariae, the Radix Aucklandiae, Rhizoma Dioscoreae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, Carapax Trionycis, Squama Manis, Radix Paeoniae Rubra, Cortex Moutan, Semen Persicae, Radix Scutellariae, Retinervus Luffae Fructus, Rhizoma Atractylodis, Radix Puerariae, Cortex Phellodendri, Radix Gentianae, Fructus Evodiae, Fructus Gardeniae.
Following column weight amount proportioning is mixed: Radix Codonopsis 60g, Rhizoma Atractylodis Macrocephalae 60g, Radix Astragali 25g, Scorpio 25g, Scolopendra 20g, Radix Scrophulariae 55g, Radix Aucklandiae 60g, Rhizoma Dioscoreae 80g, Radix Saposhnikoviae 60g, Radix Achyranthis Bidentatae 25g, Carapax Trionycis 25g, Squama Manis 25g, Radix Paeoniae Rubra 25g, Cortex Moutan 25g, Semen Persicae 35g, Radix Scutellariae 35g, Retinervus Luffae Fructus 45g, Rhizoma Atractylodis 30g, Radix Puerariae 45g, Cortex Phellodendri 25g, Radix Gentianae 25g, Fructus Evodiae 25g, Fructus Gardeniae 25g.
Take, concentrate, produce through measures such as high temperature sterilize, fungus-proof antisepsis.
Instructions of taking: once a day, each one, warm boiled water (medicine) being taken before meal is used.
Chinese medicine disclosed by the invention---No. 1, " Kang Yu board " vasculitis has the effect of blood circulation promoting and blood stasis dispelling, dredging the meridian, is effective to treat vasculitis, and obtains satisfied effect through experiment, and relevant experimental data is as follows:
1, selects the standard of case
Suffering from vasculitic high-risk group is smoker's (especially male adults), psychentonia person, unbalanced, the cold humid area resident of nutrition, Inheritance factor.The overwhelming majority betides the 20-40 male in year, and the women is rarely found.Evolution with primary disease divides three phases (doctor trained in Western medicine) clinically: the initial stage (ischemia phase) suffers from acroanesthesia, it is cool to send out, be afraid of cold, heavy, toes have that spasmic pain, intermittent claudication appear in pin sample pain, Calf muscle, trouble main drive arteriopalmus is faint or the migration superficial phlebitis that disappears, and General Symptoms is not remarkable.Suffer from acroanesthesia mid-term (malnutrition phase), send out cool, be afraid of cold, intermittent claudication increases the weight of, and rest pain arranged.Suffer from that limb skin often is flushing color, aubergine or pale asphyxia, pedal skin drying, decortication, toenail poor growth, thickens distortion, fine hair comes off, Calf muscle has the atrophy phenomenon, suffer from the disappearance of main drive arteriopalmus.The uneasiness of can being in a bad mood, dizzy lumbago, the disease that muscles and bones is soft.Later stage (downright bad phase) suffers from limb because ulcer or necrosis take place serious disturbance of blood circulation, and great majority are confined to toes or foot, to vertical spread to ankle joint or the shank person rarely found.Sharp ache unbearably, the patient often sits with one's arms about one's knees, and beats breast and stamp feet, and cries loudly and cries, and is overwhelmed with sorrow.After the toes of gangrene come off, often leave over ulcer and prolonged disunion.Whole body is often with symptom such as heating, xerostomia, loss of appetite, insomnia, constipation, yellowish urine be red.Secondary performance superficial migratory thrombo-phlebitis: about 40% case occurs, and mainly occurs in saphena and branch thereof.Tremulous pulse infringement: the most normal what get involved is dorsal artery of foot, secondly is tremulous pulse and femoral artery.The histotrophic nutrition obstacle: if pathological changes further develops, pain also appears in local severe ischemic during rest.Local osteoporosis: ischemia can cause local osteoporosis, not only aggravates the pain, and because of local compression or bear a heavy burden then more remarkable.
Be divided into five types:
1., YIN-cold stagnates: suffer from acroanesthesia pain, local skin is pale, and that touches is ice-cold, meets cold rnning and weighs, and gets Wen Ze and subtracts.Wound pale complexion or dark red is not slowly healed.Pale tongue, white and thin fur, deep-thready pulse and late.2., blood network stasis of blood resistance: suffer from limb or suffer from toe (finger) stationarity constant pain, rest pain is obvious.Suffer from limb skin and be purplish red, dark red or livid purple, obvious especially when sagging, xerosis cutis, toenail thickens, and the meat atrophy is withered.Deep red tongue or purple dark has ecchymosis, thin white fur of tongue, and deep-thready pulse is puckery.3., damp invasion of lower energizer: suffer from the limb pain of being afraid of cold, often be migration.Sour bloated, heavy, weak during walking, streak lump or tuberosity can appear in lower limb, red and swollen heat pain, the slight ulcer of acra or gangrene.The patient can be stranded oppression sensation over the epigastrium and anorexia with the heavy body of head.Red tongue, yellowish fur or white greasy, the many stringy and rolling pulse of arteries and veins or stringy and rapid pulse.4., excessive noxious heat: suffer from limb generation ulcer or gangrene, the secondary severe infections, the purple pain is acute, swollen gesture undiscipline, pus is a lot of, the foul smelling abnormal smells from the patient.General Symptoms can have high heat shiver with cold, agitation, big dry stool, yellow urine.Deep red tongue, yellowish fur, yellow dry or dark brown tongue, the loud or stringy and thready pulse number of stringy and rolling pulse.5., QI and blood deficiency: the patient body weakness, with a haggard face sallow, it is unable to become thin, the xerosis cutis desquamation, toe (finger) first drying thickens, amyotrophy, the wound poor growth, disunion for a long time, the granulation ash is light, dark red, pus is rare clearly.Pale tongue, thin white fur of tongue, deep,thready and forceless pulse.
Patient with above-mentioned symptom all as the standard of selecting case, treats.
2, diagnostic criteria
Patient with 1 symptom all is diagnosed as the vasculitis patient.
3, therapeutic scheme
Every day every vasculitis patient, once a day, each one, the vasculitic Chinese medicine for the treatment of that warm boiled water (medicine) being taken before meal is made with the present invention---No. 1, " Kang Yu board " vasculitis, 15 days is a course for the treatment of, adds up curative effect after two courses for the treatment of.
4, efficacy assessment standard
Cure: the pain complete obiteration, no longer include any disease sense, health is normal, and life is normal.
Effectively: suffer from acroanesthesia, send out cool, the symptom of being afraid of cold and make moderate progress, pain disappears or alleviates to some extent, remains medicine further to be treated.
Invalid: suffer from acroanesthesia, send out cool, be afraid of cold, symptom do not have improvement, pain is arranged, even the trend that increases the weight of is arranged.
5, statistical processing
According to above-mentioned 3 therapeutic schemes to suffering from vasculitic 636 people, the vasculitic Chinese medicine for the treatment of-" Kang Yu board " vasculitis that adopts the present invention to make is treated for No. 1, male 388 people wherein, woman 248 people, age 20--80 year, initial stage patient 432 people, mid-terms 128 people, later stages 76 people, add up 2 courses for the treatment of as follows:
Cure 560 people, effective 72 people, invalid 4 people (people in mid-terms 2), total effective rate 91.37%, acomia existing any toxic and side effects is safe and reliable during medication.
6, conclusion
Experiment shows, the vasculitic Chinese medicine of the treatment that the present invention makes---No. 1, " Kang Yu board " vasculitis, consumption is reasonable, has effectively reached anti-inflammatory analgetic, blood circulation promoting and blood stasis dispelling, the purpose for the treatment of vasculitis, drug safety is reliable, the curative effect height, cost is low, easily producing, is the innovation on the treatment vasculitis medicine, has very high economic worth and good social benefit.

Claims (3)

1. treat vasculitic Chinese medicine for one kind, it is characterized in that: employed Chinese crude drug is as follows, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, the Radix Astragali, Scorpio, Scolopendra, Radix Scrophulariae, the Radix Aucklandiae, Rhizoma Dioscoreae, Radix Saposhnikoviae, Radix Achyranthis Bidentatae, Carapax Trionycis, Squama Manis, Radix Paeoniae Rubra, Cortex Moutan, Semen Persicae, Radix Scutellariae, Retinervus Luffae Fructus, Rhizoma Atractylodis, Radix Puerariae, Cortex Phellodendri, Radix Gentianae, Fructus Evodiae, Fructus Gardeniae.
2. according to the vasculitic Chinese medicine of the described treatment of claim 1, it is characterized in that, press following weight proportion manufacturing: Radix Codonopsis 50-80g, Rhizoma Atractylodis Macrocephalae 50-80g, Radix Astragali 20-30g, Scorpio 20-30g, Scolopendra 20-30g, Radix Scrophulariae 50-80g, Radix Aucklandiae 50-20g, Rhizoma Dioscoreae 50-130g, Radix Saposhnikoviae 50-70g, Radix Achyranthis Bidentatae 20-30g, Carapax Trionycis 20-30g, Squama Manis 20-30g, Radix Paeoniae Rubra 20-30g, Cortex Moutan 20-30g, Semen Persicae 30-40g, Radix Scutellariae 30-50g, Retinervus Luffae Fructus 40-50g, Rhizoma Atractylodis 30-50g, Radix Puerariae 40-50g, Cortex Phellodendri 20-30g, Radix Gentianae 20-30g, Fructus Evodiae 20-30g, Fructus Gardeniae 20-30g.
3. according to the vasculitic Chinese medicine of the described treatment of claim 2, it is characterized in that: optimum weight proportion is as follows: Radix Codonopsis 60g, Rhizoma Atractylodis Macrocephalae 60g, Radix Astragali 25g, Scorpio 25g, Scolopendra 20g, Radix Scrophulariae 55g, Radix Aucklandiae 60g, Rhizoma Dioscoreae 80g, Radix Saposhnikoviae 60g, Radix Achyranthis Bidentatae 25g, Carapax Trionycis 25g, Squama Manis 25g, Radix Paeoniae Rubra 25g, Cortex Moutan 25g, Semen Persicae 35g, Radix Scutellariae 35g, Retinervus Luffae Fructus 45g, Rhizoma Atractylodis 30g, Radix Puerariae 45g, Cortex Phellodendri 25g, Radix Gentianae 25g, Fructus Evodiae 25g, Fructus Gardeniae 25g.
CN2013101132836A 2013-04-03 2013-04-03 Tradtional Chinese medicine for treating angiitis Pending CN103191280A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013101132836A CN103191280A (en) 2013-04-03 2013-04-03 Tradtional Chinese medicine for treating angiitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013101132836A CN103191280A (en) 2013-04-03 2013-04-03 Tradtional Chinese medicine for treating angiitis

Publications (1)

Publication Number Publication Date
CN103191280A true CN103191280A (en) 2013-07-10

Family

ID=48714214

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013101132836A Pending CN103191280A (en) 2013-04-03 2013-04-03 Tradtional Chinese medicine for treating angiitis

Country Status (1)

Country Link
CN (1) CN103191280A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103566345A (en) * 2013-10-11 2014-02-12 王纯治 Traditional Chinese medicine mixture for treating varicocele
CN105106538A (en) * 2015-09-02 2015-12-02 张希富 Traditional Chinese medicine composition for treating angiitis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679843A (en) * 2005-01-27 2005-10-12 朱腾月 Oral medicine for treating thromboangitis obliterans

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679843A (en) * 2005-01-27 2005-10-12 朱腾月 Oral medicine for treating thromboangitis obliterans

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
郭勇义等: "血栓闭塞性脉管炎的中医药内治法研究进展", 《河南中医学院学报》, no. 01, 20 February 2004 (2004-02-20) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103566345A (en) * 2013-10-11 2014-02-12 王纯治 Traditional Chinese medicine mixture for treating varicocele
CN103566345B (en) * 2013-10-11 2015-07-15 王纯治 Traditional Chinese medicine mixture for treating varicocele
CN105106538A (en) * 2015-09-02 2015-12-02 张希富 Traditional Chinese medicine composition for treating angiitis

Similar Documents

Publication Publication Date Title
CN100506266C (en) Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae
CN100388932C (en) Method for preparing externally applied medicine for feet tinea
CN102247585A (en) Chinese medicinal composition for treating rheumatism, preparation thereof and preparation method thereof
CN102091258A (en) Chinese medicinal composition for dispelling scars and preparation method thereof
CN103656238A (en) Traditional Chinese medicine composition for treating rheumatic bone diseases
CN101337059A (en) Plaster for treating hyperosteogeny and preparation method thereof
CN101062377B (en) Adhesive plaster for diminishing inflammation, expelling wind and cold
CN111840496A (en) Intelligent system preparation for conditioning physique and preventing and treating various eczema diseases and preparation method
CN103860659A (en) Traditional Chinese medicine for treating early nephrolith
CN102846955A (en) Chinese herbal medicine heightening insole
CN103191280A (en) Tradtional Chinese medicine for treating angiitis
CN102641368A (en) Traditional Chinese medicine for treating beriberi
CN105878776A (en) Pharmaceutical composition and preparation for treating neck, shoulder, waist and leg diseases and preparation method and application of the pharmaceutical composition and the preparation
CN101884737B (en) Chinese medicinal composition for treating hemiparalysis
CN105561272A (en) Traditional Chinese medicine preparation for relieving Reynolds disease and preparation method thereof
CN104055900A (en) Traditional Chinese medicine composition for treating urticaria
CN104027451B (en) A kind of Chinese medicine for the treatment of deficiency of the liver and kindey pattern of syndrome sciatica
CN102988833A (en) Traditional Chinese medicine composition for treating rheumatism
CN107693621A (en) Chinese medicine and its preparation for coronary heart disease myocardial infarction treatment
CN102380009A (en) Chinese herbal medicine powder for treating rheumatism and administration method thereof
CN106267127A (en) A kind of Chinese medicine composition treating lumbago and skelalgia arthromyodynia and heat steam health promoting insoles
CN106421514A (en) Traditional Chinese medicine for treating arthralgia
CN105362944A (en) Traditional Chinese medicine ointment for treating orthopedics sprain and contusion
CN104306893B (en) It is a kind of for Chinese medicine preparation of the half side limbs failure of craniocerebral injury and preparation method thereof
CN103961656A (en) Traditional Chinese medicament for treating chronic venous insufficiency

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130710